Aveanna Healthcare (NASDAQ:AVAH) Stock Price Down 8.3% – Should You Sell?

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH)’s stock price fell 8.3% on Friday . The company traded as low as $4.48 and last traded at $4.43. 63,129 shares changed hands during mid-day trading, a decline of 61% from the average session volume of 163,259 shares. The stock had previously closed at $4.83.

Analyst Ratings Changes

Separately, Truist Financial dropped their target price on Aveanna Healthcare from $6.00 to $5.25 and set a “hold” rating for the company in a research report on Monday, January 6th.

Aveanna Healthcare Stock Performance

The stock has a 50-day moving average of $4.70 and a two-hundred day moving average of $5.02. The company has a market cap of $827.99 million, a P/E ratio of -12.66 and a beta of 2.24.

Institutional Trading of Aveanna Healthcare

Several hedge funds and other institutional investors have recently bought and sold shares of AVAH. SG Americas Securities LLC bought a new stake in Aveanna Healthcare in the third quarter valued at approximately $101,000. Creative Planning lifted its position in Aveanna Healthcare by 21.3% in the third quarter. Creative Planning now owns 48,502 shares of the company’s stock valued at $252,000 after purchasing an additional 8,502 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. bought a new stake in Aveanna Healthcare in the third quarter valued at approximately $817,000. Intech Investment Management LLC bought a new stake in Aveanna Healthcare in the third quarter valued at approximately $69,000. Finally, Charles Schwab Investment Management Inc. lifted its position in Aveanna Healthcare by 3.9% in the third quarter. Charles Schwab Investment Management Inc. now owns 462,659 shares of the company’s stock valued at $2,406,000 after purchasing an additional 17,522 shares during the last quarter. Institutional investors own 87.96% of the company’s stock.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.